Abstract:BACKGROUND:The new tetrandrine derivative is an anti-human liver cancer cell inhibitor which can be used to design and develop anti-human-liver-cancer drugs.OBJECTIVE:A quantitative structure-activity relationship (QSAR) model was established to predict the physical properties of new tetrandrine derivatives using their chemical structures.METHODS:The best descriptors were selected through CODESSA software to build a multiple linear regression model. Then, gene expression programming (GEP) was used to establish a nonlinear quantitative QSAR model with descriptors to predict the activity of a series of novel tetrandrine chemotherapy drugs. The best active compound 31 was subjected to molecular docking experiments through SYBYL software with a small fragment of the protein receptor (PDB ID:2J6M).RESULTS:Four descriptors were selected to build a multiple linear regression model with correlation coefficients R2, R2CV and S2 with the values of 0.8352, 0.7806 and 0.0119, respectively. The training and test sets with a correlation coefficient of 0.85 and 0.83 were obtained via an automatic problem-solving program (APS) using the four selected operators as parameters, with a mean error of 1.49 and 1.08. Compound 31 had a good docking ability with an overall score of 5.8892, a collision rate of -2.8004 and an extreme value of 0.9836.CONCLUSION:The computer-constructed drug molecular model reveals the factors affecting the activity of human hepatocellular carcinoma cells, which provides directions and guidance for the development of highly effective anti-humanhepatocellular- carcinoma drugs in the future.

QSAR Model Study of 2,3,4,5-Tetrahydro-1h-pyrido[4,3-b]indole of Cystic- Brosis-Transmembrane Conductance-regulator Gene Potentiators

QSAR Research of Novel Tetrandrine Derivatives Against Human Hepatocellular Carcinoma.

QSAR Studies on the IC50 of a Class of Thiazolidinone/Thiazolide Based Hybrids As Antitrypanosomal Agents

Studies on the IC50 of Trisubstituted Thiazoles As Cdc7 Kinase Inhibitors

3D-QSAR and Molecular Docking Study on Selectivity of Indolocarbazole Series As Cyclin-Dependent Kinase Inhibitors

Prediction of Antitumor Activities of Indolo[1,2-b]Quinazoline Derivatives Using Electrotopological State Indices for AtomTypes

QSAR study of 1,4-dihydropyridine calcium channel antagonists based on gene expression programming

A Linear and Nonlinear QSAR Analysis of Benzimidazole Derivative XY123 in Prostate Cancer Treatment

QSAR Study of Ethyl 2-[(3-methyl-2,5-dioxo(3-pyrrolinyl))amino]-4-(trifluoromethyl) Pyrimidine-5-carboxylate: an Inhibitor of AP-1 and NF-κB Mediated Gene Expression Based on Support Vector Machines

A QSAR study of 1,2-diarylimidazole cyclooxygenase-2 inhibitors

1-Benzylspiro[piperidine-4,1'-pyrido[3,4-b]indole] 'Co-Potentiators' for Minimal Function CFTR Mutants.

3D-QSAR study for VEGFR-2 inhibitors of imidazolepyridine derivatives with different charge fields

Combined 3D-QSAR modeling and molecular docking study on 1,4-dihydroindeno[1,2-c]pyrazoles as VEGFR-2 kinase inhibitors.

Quantitative Structure-Activity Relationships (qsar): Studies of Inhibitors of Tyrosine Kinase

Activity prediction of hepatitis C virus NS5B polymerase inhibitors of pyridazinone derivatives

The index of ideality of correlation: QSAR studies of hepatitis C virus NS3/4A protease inhibitors using SMILES descriptors

Development of in Silico Models for Pyrazoles and Pyrimidine Derivatives As Cyclin-Dependent Kinase 2 Inhibitors

Proposal and Evaluation of a New Norm Index-Based QSAR Model to Predict Pec 50 and Pcc 50 Activities of HEPT Derivatives

3D-QSAR, Molecular Docking and Molecular Dynamics Simulations Study of 3-Pyrimidin-4-yl-oxazolidin-2-one Derivatives to Explore the Structure Requirements of Mutant IDH1 Inhibitors

Receptor and ligand-based 3D-QSAR study on a series of pyrazines/pyrrolidylquinazolines as inhibitors of PDE10A enzyme

In silico design novel dihydropyrimio[4, 5-d]pyrimidine derivatives as inhibitors for colony-stimulating factor-1 receptor based on 3D-QSAR, molecular docking and molecular dynamics simulation